Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04450173 |
| Title | Obinutuzumab, Ibrutinib, and Venetoclax for the Treatment of Previously Untreated Stage II-IV Follicular Lymphoma |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | University of California, Davis |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of California, San Francisco (UCSF) Fresno | Fresno | California | 93701 | United States | Details | |
| University of California, Los Angeles | Los Angeles | California | 90095 | United States | Details | |
| University of California Davis Comprehensive Cancer Center | Sacramento | California | 95817 | United States | Details | |
| University of California, San Diego | San Diego | California | 92037 | United States | Details |